A canine-derived chimeric antibody with high neutralizing activity against canine parvovirus-2

oleh: Lixuan Zhou, Hongchao Wu, Mengmeng Du, Huanhuan Song, Ningning Huo, Xiao Chen, Xiaorui Su, Weiguo Li, Lulu Wang, Jie Wang, Baicheng Huang, Feifei Tan, Kegong Tian

Format: Article
Diterbitkan: SpringerOpen 2022-06-01

Deskripsi

Key points A canine-derived chimeric MAb 11D9 was produced by CHO cell lines. The MAb 11D9 exhibited high HI and neutralization titers against new CPV-2 variants. The MAb 11D9 had a high therapeutic effect in beagles infected with the new CPV-2a variant.